BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999;44:754-758. [PMID: 10205219 DOI: 10.1136/gut.44.5.754] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Nandini C, Madhunapantula SV, Bovilla VR, Ali M, Mruthunjaya K, Santhepete MN, Jayashree K. Platelet enhancement by Carica papaya L. leaf fractions in cyclophosphamide induced thrombocytopenic rats is due to elevated expression of CD110 receptor on megakaryocytes. J Ethnopharmacol 2021;275:114074. [PMID: 33831466 DOI: 10.1016/j.jep.2021.114074] [Reference Citation Analysis]
2 Mehta AB, Burroughs AK. Thrombopoietin concentration after orthotopic liver transplantation: Correspondence. British Journal of Haematology 2001;114:954-62. [DOI: 10.1046/j.1365-2141.2001.03006-7.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Hugenholtz GG, Porte RJ, Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis. 2009;13:11-20. [PMID: 19150305 DOI: 10.1016/j.cld.2008.09.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
4 Pereboom IT, Lisman T, Porte RJ. Platelets in liver transplantation: friend or foe? Liver Transpl. 2008;14:923-931. [PMID: 18581510 DOI: 10.1002/lt.21510] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
5 Stasi R, Chia LW, Kalkur P, Lowe R, Shannon MS. Pathobiology and treatment of hepatitis virus-related thrombocytopenia. Mediterr J Hematol Infect Dis 2009;1:e2009023. [PMID: 21415958 DOI: 10.4084/MJHID.2009.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
6 Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E, Podesta E, Chiarbonello B, Polegato S, Mamone M, Testa R. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterology 2003;98:2516-20. [DOI: 10.1111/j.1572-0241.2003.08665.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
7 Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81-85. [PMID: 11743252 DOI: 10.1097/00004836-200201000-00016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 115] [Article Influence: 6.8] [Reference Citation Analysis]
8 Seth AK, Gunson BK, Mirza DF, Haydon G. Thrombocytosis in liver transplant recipients: Prevalence, natural history, and impact. Liver Transpl 2007;13:1598-602. [DOI: 10.1002/lt.21294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-S14. [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
10 Eyraud D, Granger B, Ionescu C, Fratéa S, Darnat S, Vaillant JC, Siksik JM, Hannoun L, Coriat P. Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis. Liver Transpl 2012;18:340-6. [PMID: 22006447 DOI: 10.1002/lt.22456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
11 Potze W, Porte RJ, Lisman T. Management of coagulation abnormalities in liver disease. Expert Review of Gastroenterology & Hepatology 2014;9:103-14. [DOI: 10.1586/17474124.2014.934673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
12 Nomura T, Kubota Y, Kitanaka A, Kurokouchi K, Inage T, Saigo K, Iseki K, Baba N, Yamaoka G, Arai T. Immature platelet fraction measurement in patients with chronic liver disease: a convenient marker for evaluating cirrhotic change. Int J Lab Hematol. 2010;32:299-306. [PMID: 19694836 DOI: 10.1111/j.1751-553X.2009.01184.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Trotter JF. Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 2006;10:665-78. [DOI: 10.1016/j.cld.2006.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
14 Senzolo M, Burra P, Cholongitas E, Burroughs A. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006; 12(48): 7725-7736 [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
15 Doria C, Mandalà L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004;18:365-71. [PMID: 15233811 DOI: 10.1111/j.1399-0012.2004.00172.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
16 Weksler BB. Review article: the pathophysiology of th-rombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26 Suppl 1:13-19. [PMID: 17958515 DOI: 10.1111/j.1365-2036.2007.03512.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
17 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
18 Qamar AA, Grace ND. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009;23:441-5. [PMID: 19543577 DOI: 10.1155/2009/591317] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
19 Kargili A, Cipil H, Karakurt F, Kasapoglu B, Koca C, Aydn M, Uysal S, İkizek M, Uz E, Balcik OS, Kosar A. Hemostatic alterations in fatty liver disease: . Blood Coagulation & Fibrinolysis 2010;21:325-7. [DOI: 10.1097/mbc.0b013e328337b3f8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
20 Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY, Lee SD. Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(17): 2472-2477 [PMID: 15300887 DOI: 10.3748/wjg.v10.i17.2472] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
21 Romanelli RG, Petrai I, Robino G, Efsen E, Novo E, Bonacchi A, Pagliai G, Grossi A, Parola M, Navari N, Delogu W, Vizzutti F, Rombouts K, Gentilini P, Laffi G, Marra F. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;290:G120-8. [DOI: 10.1152/ajpgi.00350.2004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
22 Rauber P, Lammert F, Grotemeyer K, Appenrodt B. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study. PLoS One 2018;13:e0192271. [PMID: 29438423 DOI: 10.1371/journal.pone.0192271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
23 Liu Q, Ma K, He Z, Dong J, Hua X, Huang X, Qiao L. Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study. J Gastrointest Surg. 2005;9:648-657. [PMID: 15862259 DOI: 10.1016/j.gassur.2004.11.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
24 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
25 Pandey P, Tiwari AK, Sharma J, Srivastava D, Dixit S, Raina V. Perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: A cross sectional study. Asian J Transfus Sci 2013;7:68-72. [PMID: 23559770 DOI: 10.4103/0973-6247.106743] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1267-1276. [PMID: 12774004 DOI: 10.1053/jhep.2003.50209] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
27 Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 2014;25:576-86. [PMID: 24246132 DOI: 10.3109/09537104.2013.849335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
28 Barosi G, Vittorio R, Margherita M, Luca VG, Alessandro P, Vittorio N, Isabella R, Rita C, Monia M, Mario B, Umberto M. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia: Spleen Neoangiogenesis in MMM. British Journal of Haematology 2004;124:618-25. [DOI: 10.1111/j.1365-2141.2004.04829.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
29 Klammt S, Mitzner SR, Reisinger EC, Stange J. No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial. Ther Apher Dial 2014;18:502-8. [PMID: 25195684 DOI: 10.1111/1744-9987.12124] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Rodríguez-Castro KI, Antonello A, Ferrarese A. Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? World J Hepatol 2015; 7(14): 1818-1827 [PMID: 26207163 DOI: 10.4254/wjh.v7.i14.1818] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
31 Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35:473-478. [PMID: 12870732 DOI: 10.1016/s1590-8658(03)00219-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
32 Bissonnette J, Valla D, Rautou PE. Managing periprocedural thrombocytopenia in cirrhosis: aiming for a safety window. J Hepatol 2014;61:1199-201. [PMID: 25219886 DOI: 10.1016/j.jhep.2014.08.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 McCormick PA, Malone DE, Docherty JR, Kiat C, Christopher BT, Chin JL. Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressure. Eur J Gastroenterol Hepatol 2019;31:352-6. [PMID: 30334908 DOI: 10.1097/MEG.0000000000001286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol. 2005;100:1311-1316. [PMID: 15929762 DOI: 10.1111/j.1572-0241.2005.41543.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
35 Barton CA. Treatment of Coagulopathy Related to Hepatic Insufficiency: . Critical Care Medicine 2016;44:1927-33. [DOI: 10.1097/ccm.0000000000001998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Grieve A, Makin E, Davenport M. Aspartate Aminotransferase-to-Platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation. J Pediatr Surg 2013;48:789-95. [PMID: 23583135 DOI: 10.1016/j.jpedsurg.2012.10.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
37 Franchini M, Veneri D, Lippi G. Thrombocytopenia and infections. Expert Rev Hematol 2017;10:99-106. [PMID: 27936979 DOI: 10.1080/17474086.2017.1271319] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
38 Stanca C, Fiel M, Aledort L, Cohen E, del Rio Martin J, Schiano T. Factors Associated With Persistent Thrombocytopenia after Liver Transplantation. Transplantation Proceedings 2010;42:1769-73. [DOI: 10.1016/j.transproceed.2010.02.075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
39 Sommacale D, Nagarajan G, Lhuaire M, Dondero F, Pessaux P, Piardi T, Sauvanet A, Kianmanesh R, Belghiti J. Surgical procedures in liver transplant patients: A monocentric retrospective cohort study. International Journal of Surgery 2017;41:58-64. [DOI: 10.1016/j.ijsu.2017.03.058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
40 Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23:1055-1065. [PMID: 16611265 DOI: 10.1111/j.1365-2036.2006.02889.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 8.3] [Reference Citation Analysis]
41 Tacke F, Trautwein C, Zhao S, Andreeff M, Manns MP, Ganser A, Schöffski P. Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis. Liver. 2002;22:205-212. [PMID: 12100570 DOI: 10.1034/j.1600-0676.2002.01642.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
42 Campanelli R, Fois G, Catarsi P, Poletto V, Villani L, Erba BG, Maddaluno L, Jemos B, Salmoiraghi S, Guglielmelli P, Abbonante V, Di Buduo CA, Balduini A, Iurlo A, Barosi G, Rosti V, Massa M; AGIMM Investigators. Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis. PLoS One 2016;11:e0156990. [PMID: 27281335 DOI: 10.1371/journal.pone.0156990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Weitzman G, Schamberg NJ, Lake-Bakaar G. Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE. Dig Dis Sci. 2007;52:3270-3274. [PMID: 17638078 DOI: 10.1007/s10620-006-9371-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
44 Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M. Right liver lobe/albumin ratio: Contribution to non-invasive assessment of portal hypertension. World J Gastroenterol 2007; 13(40): 5331-5335 [PMID: 17879402 DOI: 10.3748/wjg.v13.i40.5331] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
45 Danish FI, Yasmin S. The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med 2013;5:17-30. [PMID: 24696622 DOI: 10.2147/HMER.S27100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
46 Haegele S, Offensperger F, Pereyra D, Lahner E, Assinger A, Fleischmann E, Gruenberger B, Gruenberger T, Brostjan C, Starlinger P. Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction. PLoS One 2015;10:e0116985. [PMID: 25611592 DOI: 10.1371/journal.pone.0116985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
47 McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:1009-1031. [PMID: 11139352 DOI: 10.1053/bega.2000.0144] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 4.0] [Reference Citation Analysis]
48 Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:21-8. [PMID: 17958516 DOI: 10.1111/j.1365-2036.2007.03509.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
49 Vadlapudi SS, Jagadisan B, Ananthkrishnan R, Narayanaswamy S. Splenic stiffness and platelet count to predict varices needing treatment in pediatric extrahepatic portal vein obstruction. Indian J Gastroenterol 2020;39:576-83. [PMID: 33231766 DOI: 10.1007/s12664-020-01099-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
51 Göker H, Egesel T, Karakuş S, Haznedaroglu IC, Apraş Ş, Büyükaşik Y, Sayinalp N, özcebe OI, Dundar S, Kirazli Ş, Bayraktar Y. Plasma Thrombopoietin in Patients With Cavernous Transformation of the Portal Vein. Int J Hematol 2002;75:91-4. [DOI: 10.1007/bf02981986] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol. 2001;13:791-801. [PMID: 11474308 DOI: 10.1097/00042737-200107000-00006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
53 Mori S, Park MS, Kim H, Choi Y, Hong G, Yi NJ, Lee KW, Suh KS. Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. Int Surg. 2015;100:524-530. [PMID: 25785339 DOI: 10.9738/intsurg-d-14-00016.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
54 Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23:1275-1297. [PMID: 19932434 DOI: 10.1016/j.hoc.2009.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
55 Campanelli R, Rosti V, Villani L, Castagno M, Moretti E, Bonetti E, Bergamaschi G, Balduini A, Barosi G, Massa M. Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis. Cytokine 2011;53:100-6. [DOI: 10.1016/j.cyto.2010.07.427] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
56 Hayashi H, Beppu T, Masuda T, Mizumoto T, Takahashi M, Ishiko T, Takamori H, Kanemitsu K, Hirota M, Baba H. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol. 2007;22:1638-1642. [PMID: 17683504 DOI: 10.1111/j.1440-1746.2007.05090.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
57 Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250-258. [PMID: 17657149 DOI: 10.1159/000103655] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 8.5] [Reference Citation Analysis]
58 Kozek-langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013;30:270-382. [DOI: 10.1097/eja.0b013e32835f4d5b] [Cited by in Crossref: 553] [Cited by in F6Publishing: 133] [Article Influence: 69.1] [Reference Citation Analysis]
59 Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007;22:112-8. [PMID: 17201890 DOI: 10.1111/j.1440-1746.2006.04359.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
60 González-Reimers E, Quintero-Platt G, Martín-González C, Pérez-Hernández O, Romero-Acevedo L, Santolaria-Fernández F. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol 2016; 22(18): 4427-4437 [PMID: 27182154 DOI: 10.3748/wjg.v22.i18.4427] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
61 Karakan T, Cindoruk M, Degertekin B, Dogan I, Sancak A, Dumlu S, Gorgul A, Unal S. Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia. Curr Ther Res Clin Exp 2005;66:247-53. [PMID: 24764593 DOI: 10.1016/j.curtheres.2005.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Jüttner B, Brock J, Weissig A, Becker T, Studzinski A, Osthaus WA, Bornscheuer A, Scheinichen D. Dependence of platelet function on underlying liver disease in orthotopic liver transplantation. Thromb Res 2009;124:433-8. [PMID: 19616824 DOI: 10.1016/j.thromres.2009.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
63 Eissa LA, Gad LS, Rabie AM, El-gayar AM. Thrombopoietin level in patients with chronic liver diseases. Annals of Hepatology 2008;7:235-44. [DOI: 10.1016/s1665-2681(19)31854-x] [Cited by in Crossref: 15] [Article Influence: 1.2] [Reference Citation Analysis]
64 Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280-287. [PMID: 12127437 DOI: 10.1016/s0168-8278(02)00199-x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
65 Chua H, Baldwin I, Bailey M, Subramaniam A, Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. Journal of Critical Care 2012;27:744.e7-744.e15. [DOI: 10.1016/j.jcrc.2012.08.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
66 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
67 Wang CS, Yao WJ, Wang ST, Chang TT, Chou P. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin Infect Dis. 2004;39:790-796. [PMID: 15472809 DOI: 10.1086/423384] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
68 Janssen H, Lange R, Erhard J, Malagó M, Eigler FW, Broelsch CE. Causative factors, surgical treatment and outcome of incisional hernia after liver transplantation. Br J Surg. 2002;89:1049-1054. [PMID: 12153634 DOI: 10.1046/j.1365-2168.2002.02165.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
69 Herz S, Puhl G, Spies C, Jörres D, Neuhaus P, von Heymann C. [Perioperative anesthesia management of extended partial liver resection. Pathophysiology of hepatic diseases and functional signs of hepatic failure]. Anaesthesist 2011;60:103-17. [PMID: 21293838 DOI: 10.1007/s00101-011-1852-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
70 Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, De Angelis V, Pozzato G. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54:894-900. [PMID: 21145808 DOI: 10.1016/j.jhep.2010.08.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 6.4] [Reference Citation Analysis]
71 Weil D, Di Martino V, Mourey G, Biichle S, Renaudin A, Laheurte C, Cypriani B, Delabrousse E, Grandclément E, Thévenot T, Saas P; the MICROCIR Study Group. Small Annexin V-Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal Study. Clin Transl Gastroenterol 2021;12:e00333. [PMID: 33908373 DOI: 10.14309/ctg.0000000000000333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Fagundes EDT, Ferreira AR, Roquete MLV, Penna FJ, Goulart EMA, Filho PPF, Bittencourt PFS, Carvalho SD, Albuquerque W. Clinical and Laboratory Predictors of Esophageal Varices in Children and Adolescents With Portal Hypertension Syndrome. Journal of Pediatric Gastroenterology & Nutrition 2008;46:178-83. [DOI: 10.1097/mpg.0b013e318156ff07] [Cited by in Crossref: 45] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
73 Muciño-bermejo J, Carrillo-esper R, Uribe M, Méndez-sánchez N. Coagulation abnormalities in the cirrhotic patient. Annals of Hepatology 2013;12:713-24. [DOI: 10.1016/s1665-2681(19)31312-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 4.4] [Reference Citation Analysis]
74 Zhang J, Qiu Y, He X, Mao W, Han Z. Platelet-to-white blood cell ratio: A novel and promising prognostic marker for HBV-associated decompensated cirrhosis. J Clin Lab Anal 2020;34:e23556. [PMID: 32893950 DOI: 10.1002/jcla.23556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio E, Kissi HY, Touré A, Doffou S, Konaté I, Attia AK, Camara MB, Ndri-Yoman TA. Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa). Gastroenterol Res Pract 2012;2012:216390. [PMID: 22888334 DOI: 10.1155/2012/216390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
76 Gerli G, Vanelli C, Turri O, Erario M, Gardellini A, Pugliano M, Biondi ML. SDF1-3'A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events. Clin Chem 2005;51:2411-4. [PMID: 16306115 DOI: 10.1373/clinchem.2005.057802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
77 Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G, Meli V, Marchetti M, Hoffman R, Barosi G. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23:5688-5695. [PMID: 16110028 DOI: 10.1200/jco.2005.09.021] [Cited by in Crossref: 58] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
78 Shimabukuro R, Kawanaka H, Tomikawa M, Akahoshi T, Konishi K, Yoshida D, Anegawa G, Uehara H, Hashimoto N, Hashizume M, Maehara Y. Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model. Surg Today 2009;39:1054-9. [DOI: 10.1007/s00595-008-4054-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
79 Yamada A, Fujinaga Y, Suzuki T, Komatsu D, Kitoh Y, Iwadate Y, Nozaki A, Ueda K, Kadoya M. Quantitative estimation of progression of chronic liver disease using gadoxetate disodium-enhanced magnetic resonance imaging: Quantitative MR imaging in chronic liver disease. Hepatol Res 2018;48:735-45. [DOI: 10.1111/hepr.13069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Chin JL, Chan G, Ryan JD, McCormick PA. Spleen stiffness can non-invasively assess resolution of portal hypertension after liver transplantation. Liver Int. 2015;35:518-523. [PMID: 25074281 DOI: 10.1111/liv.12647] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
81 Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 2001;98:3249-55. [PMID: 11719361 DOI: 10.1182/blood.v98.12.3249] [Cited by in Crossref: 156] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
82 Laffi G, Tarquini R, Marra F. Thrombocytopenia in chronic liver disease: lessons from transplanted patients. J Hepatol 2007;47:625-9. [PMID: 17869369 DOI: 10.1016/j.jhep.2007.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
83 Giannini E, Borro P, Botta F, Fumagalli A, Malfatti F, Podestà E, Romagnoli P, Testa E, Chiarbonello B, Polegato S. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol. 2002;37:572-577. [PMID: 12399221 DOI: 10.1016/s0168-8278(02)00274-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
84 Latorre R, Vaquero J, Rincón D, Puerto M, Ponce MD, Sarnago F, Matamoros JA, Ramón E, Elizaga J, Bañares R, Ripoll C. Determinants of platelet count are different in patients with compensated and decompensated cirrhosis. Liver Int 2016;36:232-9. [DOI: 10.1111/liv.12908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
85 Ishizu Y, Ishigami M, Hayashi K, Honda T, Kuzuya T, Ito T, Fujishiro M. Rapid increase of platelet counts during antiviral therapy in patients with hepatitis C virus infection. Hepatol Res 2020;50:47-56. [PMID: 31496023 DOI: 10.1111/hepr.13426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
86 Chin JL, Hisamuddin SH, O'Sullivan A, Chan G, McCormick PA. Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation. Clin Appl Thromb Hemost 2016;22:351-60. [PMID: 25430936 DOI: 10.1177/1076029614559771] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
87 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 10.7] [Reference Citation Analysis]
88 Schöffski P, Tacke F, Trautwein C, Martin MU, Caselitz M, Hecker H, Manns MP, Ganser A. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver. 2002;22:114-120. [PMID: 12028404 DOI: 10.1034/j.1600-0676.2002.01547.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]